No abstract available
MeSH terms
-
Histiocytosis, Langerhans-Cell* / complications
-
Histiocytosis, Langerhans-Cell* / drug therapy
-
Histiocytosis, Langerhans-Cell* / genetics
-
Humans
-
Leukemia, Myelomonocytic, Chronic* / complications
-
Leukemia, Myelomonocytic, Chronic* / drug therapy
-
Leukemia, Myelomonocytic, Chronic* / genetics
-
Mutation
-
Proto-Oncogene Proteins B-raf / genetics
-
Vemurafenib / therapeutic use
Substances
-
Vemurafenib
-
BRAF protein, human
-
Proto-Oncogene Proteins B-raf